{"database":"GEO","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Other":["ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE331nnn/GSE331507/"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Genomics"],"species":["Homo sapiens"],"gds_type":["Genome binding/occupancy profiling by high throughput sequencing"," Expression profiling by high throughput sequencing"],"full_dataset_link":["https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE331507"],"repository":["GEO"],"entry_type":["GSE"],"additional_accession":[]},"is_claimable":false,"name":"Multi-omics profiling of glioma cells treated with I-BRD9","description":"BRD9 is a glioma-associated epigenetic regulator. This study profiles transcriptomic and chromatin-level changes in glioma cells after I-BRD9 treatment. RNA-seq was performed in U87MG and SKMG-1 cells, and ATAC-seq and BRD9 CUT&Tag were performed in U87MG cells. These datasets were used to characterize changes in gene expression, chromatin accessibility, and BRD9-associated chromatin signals after BRD9 inhibition.","dates":{"publication":"2026/05/25"},"accession":"GSE331507","cross_references":{"GSM":["GSM9748305","GSM9748304","GSM9748307","GSM9748306","GSM9748301","GSM9748289","GSM9748300","GSM9748303","GSM9748302","GSM9748297","GSM9748296","GSM9748299","GSM9748288","GSM9748298","GSM9748293","GSM9748292","GSM9748295","GSM9748294","GSM9748291","GSM9748290"],"GPL":["34284"],"GSE":["331507"],"taxon":["Homo sapiens"]}}